Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

Update Il y a 4 ans
Reference: NCT00255463

Woman Man

Extract

The purpose of this study is to compare the changes in a proliferation biomarker in subjects receiving Anastrozole or Anastrozole/ZD1839 combination.


Inclusion criteria

  • Breast Cancer


Links